Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 148 | 188 | 2,633 | 236 | 702 |
| Gross Profit | 148 | 188 | 2,633 | 236 | 702 |
| Operating Expenses | 2,308 | 3,672 | 4,938 | 5,430 | 9,278 |
| Operating Income | -2,160 | -3,485 | -2,305 | -5,194 | -8,576 |
| Interest Expense | 0 | 0 | 0 | 65 | 0 |
| Other Income | -71 | 54 | -205 | -8 | 640 |
| Pre-tax Income | -2,231 | -3,431 | -2,510 | -5,267 | -7,937 |
| Net Income Continuous | -2,231 | -3,431 | -2,510 | -5,267 | -7,937 |
| Net Income Discontinuous | 414 | -29 | -19 | -22 | -94 |
| Minority Interests | -272 | N/A | N/A | N/A | 0 |
| Net Income | $-1,545 | $-3,460 | $-2,529 | $-5,289 | $-8,031 |
| EPS Basic Total Ops | -0.30 | -0.60 | -0.60 | -1.20 | -1.90 |
| EPS Basic Continuous Ops | -0.40 | -0.60 | -0.60 | -1.20 | -1.90 |
| EPS Basic Discontinuous Ops | 0.10 | -0.03 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.30 | -0.60 | -0.60 | -1.20 | -1.90 |
| EPS Diluted Continuous Ops | -0.40 | -0.60 | -0.60 | -1.20 | -1.90 |
| EPS Diluted Discontinuous Ops | 0.10 | -0.03 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-1,986 | $-3,283 | $-2,039 | $-4,955 | $-8,289 |